. X-ray crystal data and structure refinement details for C-2 and C-3. 
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Reagents and Synthesis. Ruthenium trichloride hydrate (RuCl3xH2O, 40% Ru) was purchased from Pressure Chemical and used as received. Solvents were of ACS grade and used as received. All other reagents were obtained commercially and used as received. Potassium pentachloronitrosylruthenate (K2[Ru(NO)Cl5]) and potassium octachloro--nitridodiaquaruthenate (IV) (K3[Ru2(µ-N)Cl8(OH2)2]) were prepared by literature procedures.
1,2 Water (18 M·cm) was purified using a ELGA PURELAB flex 2. C-1 was synthesized as previously described using the [Ru(NH3)5Cl]Cl method. 3 Physical Measurements. NMR spectra were acquired on a 500 MHz Bruker AV 3HD spectrometer equipped with a broadband Prodigy cryoprobe.
1 H and 13 C{ 1 H} NMR spectra were referenced to the residual solvent peaks versus tetramethylsilane (TMS) at 0 ppm (d6-DMSO δ = 2.50 ppm). NMR spectra obtained in D2O include 0.05 % dioxane as an internal reference ( 1 H δ = 3.75 ppm; 13 
C{
1 H} δ = 67.19). UV-vis spectra were acquired using an Agilent Cary 8454 UVvisible spectrophotometer (Agilent Technologies, Santa Clara, CA). IR spectra (KBr pellets) were recorded on a Nicolet Avatar 370 DTGS (ThermoFisher Scientific, Waltham, MA). Graphite furnace atomic absorption spectroscopy (GFAAS) was performed using a Perkin Elmer PinAAcle 900z spectrometer (Perkin Elmer, Waltham, MA) Elemental analyses (C, H, N, Cl) were carried out by Atlantic Microlab Inc (Norcross, GA). Elemental analysis for ruthenium was determined by GFAAS. Reverse phase high performance liquid chromatography (RP-HPLC) was performed using a LC-20AT pump with a SPD-20AV UV-vis detector monitored at 270 and 220 nm (Shimadzu, Japan) using an Ultra Aqueous C18 column (100 Å, 5 μm, 250 mm × 4.6 mm; Restek, Bellefonte, PA) at a flow rate of 1 mL/min with a mobile phase containing 0.1% trifluoroacetic acid (TFA) in H2O or MeOH. The method consisted of 5 min at 0.1% MeOH, followed by a linear gradient to 1% MeOH over 10 minutes and then 1% MeOH for 5 minutes. Fluorescence and absorbance of samples in 96 well plates were measured using a BioTek Synergy HT plate reader.
Synthesis of C-2.
In a typical procedure, 288 mg (0.440 mmol) of K3[Ru2(µ-N)Cl8(OH2)2] was dissolved in 100 mL of concentrated aqueous ammonia (d = 0.88, 18 M) in a thick-walled pressure flask with a teflon screw cap. The vessel was closed, and the solution was heated at 75 °C for 6 h to yield a turbid orange solution. (Caution! The pressure vessel becomes pressurized. The reaction should be performed in a ventilated fume hood behind a blast shield). After cooling, the orangebrown precipitate was removed by filtration and the filtrate was evaporated under reduced pressure. The resulting yellow-white solid was dissolved in 30 mL of boiling water and precipitated with the addition of 9 mL of concentrated HCl (14 M) and cooling to 0 °C. The peach colored precipitate was collected by vacuum filtration and washed with 6 M HCl (10 mL), cold water (10 mL) and acetone (10 mL). The solid was purified by reprecipitated from boiling water with more acid and cooling. The pure product was collected by vacuum filtration and washed with 6 M HCl (20 mL), ice cold water (10 mL), acetone (10 mL) and diethylether (10 mL) followed by removal of residual solvent in vacuo. In some cases, multiple precipitations with HCl were required to obtain pure product. Yield: 95. Synthesis of C-3. 100 mg (0.153 mmol) of K3[Ru2(µ-N)Cl8(OH2)2] was suspended in 1 mL of distilled water and heated to boiling. Ethylene diamine (1 mL; 14.95 mmol) was separately heated in 1 mL of distilled water and heated to boiling before being added to the ruthenium suspension. The mixture was heated to reflux for 3 h. The resulting orange solution was cooled to room temperature before 9 mL of concentrated (12 M) HCl was added and the solution was further cooled to 0 ºC. The orange precipitate was collected by filtration, reprecipitated from hot aqueous solution using concentrated HCl and washed with 6M HCl (10 mL), water (10 mL), and acetone (10 mL) before drying under vacuum. Yield 27.3 mg (0.043 mmol; 28%). 1 X-ray crystallography. X-ray quality crystals of C-2 and C-3 were grown by vapor diffusion of dioxane into water (C-2) and vapor diffusion of ethanol into dilute hydrochloric acid (C-3) respectively. Low temperature X-ray diffraction (100 K) data was collected on a Rigaku XtaLAB Synergy diffractometer equipped with a 4-circle Kappa goniometer and HyPix 6000HE Hybrid S4 Photon Counting (HPC) detector with monochromated Cu K radiation ( = 1.54184 Å). Diffraction images were processed using the CrysAlisPro software (Rigaku Oxford Diffraction, The Woodlands TX). The structure was solved through intrinsic phasing using SHELXT 4 and refined against F 2 on all data by full-matrix least-squares with SHELXL 5 following established strategies. 6 All non-hydrogen atoms were refined anisotropically. Hydrogen atoms bound to carbon were included in the model at geometrically calculated positions and refined using a riding model with the isotropic displacement parameters of all hydrogen atoms fixed at 1.2 times the U value of the atoms they are linked to. For C-2, hydrogen atoms of NH3 ligands were included in the model at geometrically calculated positions and refined using a riding model, allowing the torsion angle to refine (HFIX 137). For C-3, hydrogen atoms bound to nitrogen were located in the Fourier difference map, and refined semi-freely, constraining the N-H distance to be 0.88 Å and the thermal ellipsoids to be 1.2 times that of the nitrogen atom they are bound to. In the structure of C-2, one chloride counterion was disordered over two crystallographic special positions and was treated using the PART -1 command with each part having 0.25 occupancy. In the structure of C-3, an outer sphere water molecule is disordered across a crystallographic 2-fold axis and was treated using the PART -1 command with each part having 0.5 occupancy. We were unable to locate the water hydrogen atoms in the Fourier difference map for either structure and therefore they were not included in the refinement. For C-2 the identity and location of the cation in the structure has been unequivocally determined. Attempts to deal with high residual density peaks through disorder or twinning were unsuccessful and gave nonsensical solutions. Higher residual electron density is often observed in the presence of heavy atoms due to Fourier truncation. Additionally, the highest peak (2.597) and deepest hole (2.268) are equal in magnitude and opposite in sign, suggesting that there are no unassigned atoms. Details of the structure refinement details and selected interatomic distances and angles are reported in Tables S1 -S3.   S5   Table S1 . X-ray crystal data and structure refinement details for C-2 and C-3 
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Cell Culture. HEK293 (human embryonic kidney cells were obtained from American Type Culture Collection (ATCC, Washington D.C.) and cultured as adherent monolayers in a humidified 5% CO2 atmosphere at 37 ºC in Minimum Essential Media supplemented with 10% fetal bovine serum (FBS) and 100 U/mL penicillin/streptomycin (Corning Life Sciences, Tewksbury, MA). HeLa cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% FBS and 100 U/mL penicillin/streptomycin (Corning Life Sciences, Tewksbury, MA). Cells were checked for contamination monthly using the PlasmoTest mycoplasma detection kit from InvivoGen (San Diego, CA). Ventricular cardiomyocytes were isolated from neonatal rats (NRVMs) as previously described. 7 The isolated myocytes were cultured in Ham's F-10 supplemented with 5% fetal bovine serum (FBS) and penicillin/streptomycin (100 U/ml) at 37°C in a 95% air/5% CO2 humidified atmosphere for 4 days.
Cytotoxicity measurements. Cells were seeded at 4000 cells/well in 100 L/well in a 96-well plate and incubated for 24 h. The media was removed and replaced with 200 L of growth media containing varying concentrations of the complex. After 72h of incubation, the media was replaced with MEM containing 1 mg/mL of (4,5-dimethylthiazol-2-yl)-2,5-diepheyltetrazolium bromide (MTT). After four hours incubation the media was removed and the purple formazan crystals were solubilized using 100 L of a 8/1 DMSO/glycine buffer (pH 10) mixture. The absorbance at 570 nm was measured using a BioTek Synergy HT plate reader. Whole Cell Uptake. HEK293 cells were grown to near confluence in 75 cm 2 dishes. On the day of the experiment, the culture media was removed, and the cells were washed with 1 mL PBS. The cells were then treated with culture media containing 50 µM of the complex and incubated at 37 °C for 24 h. The cells were washed with 1 mL of PBS and harvested using 0.05% trypsin (Corning Life Sciences, Tewksbury, MA). The cells were pelleted by centrifugation, resuspended in 1 mL of PBS, and pelleted again. The washing and pelleting step was repeated a total of 3 times, after which the supernatant was removed and the cells were suspended in 500 µL of lysis buffer containing 1% w/v 3-[3-cholamidopropyl)dimethylammonio]-1-propanesulfonate) (CHAPS), 5 mM ethylenediamine tetraacetic acid (EDTA), 50 mM tris(hydroxymethyl)aminomethane (Tris) and 100 mM NaCl (pH = 7.4). The suspension was vortexed for 30 s and incubated on ice for 45 minutes. Control cells not treated with the complexes were handled identically to the treated cells to correct for ruthenium present in the cells and control dishes were incubated with the complex in the absence of cells to correct for nonspecific adsorption of ruthenium to the plastic. If needed, samples were stored in -80 °C until analysis. Ruthenium and protein content of the lysates were determined as described above. Results are reported as the average mass ratio of total ruthenium to protein (pg/µg) in each sample ± SEM of three independent trials. Mitochondrial Isolation Protocol. Mitochondrial isolation was performed by a modification of previously reported protocols. [8] [9] [10] Approximately 1×10 6 HeLa cells were seeded in 75 cm 2 dishes and allowed to adhere overnight. The following day, the cell culture media was removed, and the cells were washed with 3 mL of PBS before treatment with media containing 50 µM of the complex. After 24 h, the culture media was removed, and the cell monolayer was washed with 3 mL of PBS before the cells were harvested by trypsinization. The cell suspension was centrifuged, and the resulting pellet was resuspended in 3 mL of PBS and centrifuged again to remove extracellular ruthenium. This washing step was repeated a total of three times. The cell pellet was then suspended in 500 µL of mitochondria isolation buffer containing 200 mM mannitol, 68 mM sucrose, 50 mM piperazine-N,N-bis(2-ethanesulfonic acid) (PIPES), 50 mM KCl, 5 mM EGTA, 2 mM MgCl2, 1 mM dithiothreitol (DTT), and 1:500 v/v protease inhibitor cocktail (pH = 7.4) and was incubated on ice for 20 minutes. The resulting suspension was homogenized by 35 passes through at 25-gauge needle using a 1 mL syringe. The homogenized suspension was centrifuged at 150g for 5 minutes. The supernatant was transferred to clean vial and centrifuged for 10 min at 14,000g and the remaining solid containing other cell organelles and the cell membrane was lyophilized overnight before digestion in 1 mL of tetramethylammonium hydroxide (TMAH; 25% in water) following literature procedures. 11, 12 The pelleted mitochondria were suspended in 500 µL of water and lysed by sonication. The ruthenium concentration in each sample was determined by GFAAS and was normalized to the protein content of the lysate, which was determined using the Bicinchoninic Acid Protein Assay Kit according to the manufacturer's instructions (ThermoFisher, Waltham, MA). Samples that were digested with TMAH were diluted to 2.5% TMAH with water prior to analysis. Results are reported as the mass ratio of total ruthenium to protein (pg/µg) in each sample ± standard deviation of three independent trials. Each replicate for C-2 and C-3 consisted of cells combined from four 75 cm 2 dishes. Experiments using C-1 consisted of cells combined from five 75 cm 2 dishes to account for low cell permeability. Comparison of complex localization in the mitochondria compared to extramitochondrial localization in HeLa cells. In both experiments, cells were treated with 50 µM complex for 24 h with no recovery in drug free medium. Ruthenium concentration was normalized to protein content, which was determined by a BCA assay. Data are mean of three trials ± SEM. n = 3-4, **p<0.01, ***p<0.001
Measurement of cytoplasmic and mitochondrial Ca 2+ dynamics in intact cells using Fluo-4 AM and Rhod-2 AM. HeLa cells were loaded with Fluo-4 AM (5 µM; 30 min) and rhod-2 AM (2 µM; 50 min) in extracellular medium as previously described. 13 Coverslips were mounted in an S11 open perfusion microincubator (PDMI-2; Harvard Apparatus) at 37°C and imaged. After 1 min of baseline recording, histamine (100 µM) was added, and confocal images were recorded every 3 s (510 Meta; Carl Zeiss, Inc.) at 488 and 561 nm excitation using a 40X oil objective. Images were analyzed and quantified by using ImageJ (NIH).
Measurement of cytoplasmic and mitochondrial Ca 2+ dynamics in intact cells with RGECO and GCamP6-mt. HeLa cells were transiently transfected with genetically encoded cytosolic and mitochondrial targeted Ca 2+ sensors R-GECO1 and GCamP6-mt plasmids. After 48 hours, the transfected cells were treated with MCU inhibitors (C1, C-2, and C-3; 50 µM). After 1 min of baseline recording, histamine (100 μM) was added, and the change of R-GECO1 and GCamP6-mt fluorescence were measured with 488-nm and 561-nm excitation on a Carl Zeiss META 510 confocal microscope equipped with a 40X oil objective. Images were analyzed and quantified by using ImageJ (NIH). C-labeled human MCU N-terminal domain (NTD) proteins (residues 72-189) were expressed and purified as previously described. 14 All NMR data were acquired at 35 °C on a Varian/Agilent Inova 600 MHz NMR spectrometer equipped with a room temperature HCN probe. The 1 H-15 N HSQC spectra 15 of 15 N-MCU-NTD in the presence and absence of C-2 (Ru-265) were acquired in 20 mM HEPES, 1 mM DTT, pH 7.5, 10 % (v/v) D2O. A stock Ru265 solution was prepared in the same buffer. Three dimensional (3D) HNCACB 16, 17 and CBCACONH 18 experiments used for sequential backbone amide assignments were acquired with 15 N, 13 C-MCU-NTD in 20 mM HEPES, 1 mM DTT, 150 mM KCl, pH 7.5, 10 % (v/v) D2O. The number of transients was 32, number of increments in the nitrogen dimension was 64, and the 1 H and 15 N sweep widths were 8,000 and 1,800 Hz, respectively for the 1 H-15 N-HSQC spectra. For the 3D experiments the number of transients was 24, number of increments in the nitrogen dimension was 32, number of increments in the carbon dimension was 54, and the 1 H, 15 N and 13 C sweep widths were 8,000, 1,800 and 9,600 Hz, respectively. The two-and threedimensional spectra were processed, and resonance assignments were made using NMRPipe 19 and XEASY, 20 respectively. We note that due to weak peak intensities in the 3D spectra and uncertain sequential connectivities, amide assignments are only considered tentative.
Hypoxia/reoxygenation exposure. Freshly isolated NRVMs were subjected to 16h of hypoxia (5% O2-5% CO2) followed by 8h of reoxygenation (20% O2-5%CO2) To study the protective effect of C-2, H/R was induced in NRVMs pretreated with or without C-2 (50 µM).
Simultaneous measurement of Ca 2+ Uptake and m in NRVMs. An equal number of NRVMs (6  10 6 cells) were washed in Ca 2+ free PBS, pH 7.4, resuspended and permeabilized with 40 µg/ml digitonin in 1.5 ml of intracellular medium (ICM) composed of 120 mM KCl, 10 mM NaCl, 1 mM KH2PO4, 20 mM Hepes-Tris, pH 7.2 and 2 µM thapsigargin to block the SERCA pump. All measurements were performed in the presence of 2 mM succinate. The simultaneous measurement of m and extramitochondrial Ca 2+ ([Ca   2+ ]out) clearance Were measured as above using by using the JC-1 and Fura2-FF dyes. A series of extramitochondrial Ca 2+ bolus (10 µM) was added and mitochondrial uncoupler, CCCP (2 µM), were added at the indicated time points. All the experiments were performed at 37 °C with constant stirring.
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Mitochondrial swelling assay. NRVMs were homogenized in ice-cold mitochondrial isolation buffer (10 mM sucrose, 200 mM mannitol, 5 mM HEPES, and 1 mM EGTA, pH 7.4) containing 1 mg/ml fatty acid-free bovine serum albumin. The homogenate was centrifuged for 10 min at 1000 × g, and the supernatant was centrifuged again at 14,000 × g for 10 min. The mitochondrial pellets were washed twice and centrifuged at 11,200 × g. The isolated mitochondria (1 mg protein) were added to 0.2 mL of buffer mitochondrial swelling buffer (70 mM sucrose, 230 mM mannitol, 3 mM HEPES, 2 mM Trisphosphate, 5 mM succinate). Mitochondrial swelling was measured by decrease in absorbance at 540 nm after addition of Ca 2+ (250 µM). To study the protective effect of C-2 and Ru360, mitochondrial swelling assay was performed in mitochondria treated with or without the compounds (50 µM).
